Photo from Paolo Tarantino/Twitter
Jul 14, 2023, 07:05
Can an oral, alopecia-free treatment improve outcomes for MBC vs paclitaxel? – Paolo Tarantino
Can an oral, alopecia-free treatment improve outcomes for MBC vs paclitaxel? In METEORA2, just published on JAMA Oncology by Elisabetta Munzone et al, VEX (VNR, endoxan, Xeloda) improved TTF and PFS over paclitaxel, with similar OS and at the cost of G3-4 tox.
https://jamanetwork.com/journals/jamaoncology/fullarticle/2807037